Keystone Heart, a Venus Medtech company, is a structural heart medical device company that develops and manufactures total package solutions for structural heart procedures.
Headquartered in Israel, with US operations in Tampa, FL, Keystone Heart is dedicated to advancing patient care through innovative technology and clinical research. We are committed to developing and delivering gold standard cardiac therapies that promote positive health economic outcomes. The company’s management team has extensive experience in the fields of interventional cardiology and medical devices. Keystone Heart holds and maintains a comprehensive IP portfolio and is ISO certified.
Designed to cover and protect all three major cerebral aortic arch vessels during Transcatheter Aortic Valve Replacement (TAVR) procedures.
The TriGUARD 3™ Cerebral Embolic Protection Device is CE marked. Approved for investigational use only in the US, not cleared by the US FDA.